hydroxystenozole
Sign in to saveAlso known as 17alpha-Methyl-2'H-androsta-2,4-dieno[3,2-c]pyrazol-17beta-ol
Hydroxystenozole (), also known as '17α-methylandrost-4-eno[3,2-c]pyrazol-17β-ol', is an orally active androgen/anabolic steroid (AAS) and a 17α-alkylated derivative of testosterone that was described in the literature in 1967 but was never marketed. It is closely related to stanozolol (17α-methyl-5α-androstano[3,2-c]pyrazol-17β-ol), differing from it only in hydrogenation (i.e., double bonds and their placement).
~1 min read
Encyclopedic overview
1 sectionsContents
- References
Hydroxystenozole (), also known as '17α-methylandrost-4-eno[3,2-c]pyrazol-17β-ol', is an orally active androgen/anabolic steroid (AAS) and a 17α-alkylated derivative of testosterone that was described in the literature in 1967 but was never marketed. It is closely related to stanozolol (17α-methyl-5α-androstano[3,2-c]pyrazol-17β-ol), differing from it only in hydrogenation (i.e., double bonds and their placement).
==References==
Excerpted from Wikipedia’s “hydroxystenozole” article, available under the CC BY-SA 4.0 licence.